Skip to main content

Table 2 Summary for decision-making in different pathologies during phase 2

From: A tentative guide for thoracic surgeons during COVID-19 pandemic

Pathology What to operate What to defer
NSCLC • Tumor-associated infection—compromising, but not septic (e.g., debulking for post-obstructive pneumonia)
• Tumor associated with hemorrhage, not amenable to nonsurgical treatment.
• Threatened airway
• As phase 1 in addition to any non-complicated NSCLC by infection or hemorrhage or airway obstruction
• Alternatives as phase 1 in addition to referral to phase 1 hospitals
Esophageal cancer Septic or non-septic perforation only Non-complicated by perforation cases
Postoperative complications (hemothorax, empyema, infected mesh, dehiscence of airway, anastomotic leak with sepsis) Hemodynamic stable or unstable patients Minor wound infections
Others • All emergency cases as massive hemothorax, major airway injury, airway obstruction by inhaled foreign body or advanced tracheal stenosis, and diaphragmatic hernia with strangulation
• Loculated empyema with sepsis that cannot otherwise be treated
• Tension emphysematous bullae with respiratory distress
• Recurrent pneumothorax with massive air leak
• Pectus surgery
• Hyperhidrosis
• Bronchiectasis
• Tracheal resection in tracheostomized patients
• Non-malignant pleural effusion
• Elective bullectomy
• Retained bullets with no fear of migration or embolization
• Empyema that can be drained by chest tube
• Pneumothorax for pleurodesis
  1. NSCLC non-small cell lung cancer